|
DAY 1: Monday, February 18,
2013
|
|
5th
International Conference on
Drug
Discovery & Therapy
February 18–21, 2013,
Dubai Women's College, Dubai, UAE
www.icddt.com
|
|
TIME. 10:00
a.m.
|
INAUGURAL
PROGRAM
|
|
|
|
COFFEE BREAK: 11:00 – 11:45 a.m.
|
|
JOINT PLENARY
SESSION
|
|
Time
|
Chairman: F. Murad
Co-Chairman:
R.L. Atkinson
|
Speaker
|
Title
|
|
11:45
12:30
p.m.
|
Location: Auditorium
|
Hartmut
Michel
(Nobel Laureate)
PL
|
Membrane Proteins: Importance,
Structures, Functions
|
|
12:30
1:00
p.m.
|
Location: Auditorium
|
Talal
Al Zaher
JL
|
Gulf Pharmaceutical Industries (Julphar) from Pharmaceutics to Biopharmaceutics
|
|
LUNCH BREAK: 1:00 – 1:45 p.m.
|
|
Locations
|
Lecture Hall 6
Room B-1008
Ground Floor:
Health Science Building
|
Lecture Hall 2
MPH 2
Top Floor:
Health Science Building
|
Lecture Hall 3
MPH 3
Top Floor:
Health Science Building
|
Lecture Hall 4
MPH 4
Top Floor:
Health Science Building
|
Lecture Hall 5
Room B-1001
Ground Floor:
Health Science Building
|
Lecture Hall 1
MPH 1
Top Floor:
Health Science Building
|
|
|
Chairman:
G. Muller
Co-Chairman:
E.G. Skurikhin
|
Chairman:
R.L. Atkinson
Co-Chairman:
J.W. Lillard,
Jr.
|
Chairman:
F.-M. Werner
Co-Chairman:
Z. Al-Mohsen
|
Chairman:
Y. Komarova
Co-Chairman: T. Neumann
|
Chairman:
A. Yu
Co-Chairman: F. Gansauge
|
Chairman:
A.S. el Baghdady
Co-Chairman:
R. Chaguturu
|
|
1:45
2:05
p.m.
|
Vladimir
N. Smirnov
SL
Human
Allogeneic Ab0/rh-identical Umbillical Cord Blood
Cells in the Treatment of Juvenile Patients with Cerebral Palsy
|
1:45
2:15
p.m.
|
Subrata
Chakrabarti
IL
MicroRNA
Based Therapeutics in Diabetic Vascular Complications
|
1:45
2:15
p.m.
|
Sasa
Kenjeres
IL
Computer Simulations Based
Optimization of Magnetic Drug Targeting and Delivery in Patient Specific
Vascular Geometries
|
1:45
2:15
p.m.
|
Dipak
P. Ramji
IL
Regulation
of Macrophage Foam Cell Formation by Cytokines
|
1:45
2:15
p.m.
|
Yi
Sun
IL
Targeting
Cullin-RING Ligases by MLN4924 for Novel
Anti-cancer Therapy
|
1:45
2:15
p.m.
|
Robert
Craig Deininger
IL
Translational
Research Institute Bench to Bedside Success
|
|
2:05
2:25
p.m.
|
Galina
Pavlova
SL
Protective
and Trophic Properties of GDNF and its Modifications for Cells
|
2:15
2:35
p.m.
|
Asna
Urooj
SL
Medicinal
Plants: Possible Mechanisms of Antihyperglycemic
Action
|
2:15
2:35
p.m.
|
Costas
Kiparissides
SL
Nanocarrier-based
Mucosal Delivery of Macromolecular Drugs and Antigens
|
2:15
2:45
p.m.
|
Paolo
Brunamonti Binello
IL
Management
of Coagulation's Disorders in Oral Surgery: State of Art
|
2:15
2:45
p.m.
|
Noboru
Hattori
IL
Host
Plasminogen Activator Inhibitor-1 Plays a Determinant Role in Tumor
Progression and Angiogenesis: Proposal of an Antitumor Therapy Targeting the
Host-derived Factor
|
2:15
3:15 p.m.
|
Rathnam
Chaguturu
IL
Open
Innovation-based Drug Discovery: A Promising Precompetitive Paradigm
|
|
2:25
2:45
p.m.
|
John
Yu
SL
Harnessing
Novel Biomarkers of Human Embryonic Stem Cells for Cancer Diagnosis and
Therapy
|
2:35
2:55
p.m.
|
Syed
K. Goda
SL
Isolation
and Structural Determination of Two Novel Compounds for the Control of
Diabetes Mellitus and Obesity
|
2:35
2:55
p.m.
|
Ayman
Allahham
SL
Agglomerate
Strength Distributions for Understanding the Influence of Poorly Water
Soluble Agglomerate Modifiers on the Dissolution of Indomethacin from
Interactive Mixtures
|
2:45
3:05
p.m.
|
Moses
Kayode Omole
SL
A
Ten Year Study of Management of Ischemic Heart Disease in a Tertiary Hospital
in South West Nigeria
|
2:45
3:15
p.m.
|
Mary
Bebawy
IL
Microparticle-mediated
Transfer of Drug Efflux Transporters Confers Cancer Multidrug Resistance
Withdraw
|
3:15
3:45
p.m.
|
Ibis
Sánchez-Serrano
IL
The
Core Model: Drug discovery and development via effective translational
science and public-private collaboration
|
|
2:45
3:05
p.m.
|
Piotr
Rieske
SL
SOX2
Reprograms Fibroblasts in to the Induced Stem Cells
|
2:55
3:25
p.m.
|
Fatima
Z. Basha
IL
Design,
Discovery, and Synthesis of Novel DPP-IV Inhibitors as Potential
Anti-diabetic Agents
|
2:55
3:15
p.m.
|
Mikhail
V. Khvostov
SL
Arabinogalactan
is the Tool for Improvement Bioavailability and Toxicity of Drugs
|
3:05
3:25
p.m.
|
Quadiri
Timour
SL
Protective
Effects of Ranolazine and Propranolol, alone or
Combined, on the Structural and Functional Alterations of Cardiomyocyte
Mitochondria in a Pig Model of Ischemia/Reperfusion
|
3:15
3:45
p.m.
|
Fazlul Huq
IL-25
Phytochemicals
as a Rich Source of Tumour Active Compounds for
Combination with Targeted Therapy Towards Overcoming Drug Resistance in
Cancer
|
3:45
4:15
p.m.
|
Assem
S. el Baghdady
IL
Successful
collaboration between Academia and the pharmaceutical industry
: A Dream or Reality?
|
|
3:05
3:25
p.m.
|
Costas Kiparissides
SL
CFD Simulation
of a Dry Powder Inhaler and Particles Deposition in the Respiratory Tract
|
3:25
3:45
p.m.
|
R.D.
Lele
SL
Osmotin
(Plant Analog of Adiponection): As a Therapeutic
Agents
|
3:15
3:35
p.m.
|
Rana
Bakhaiaer
SL
Gene
Expression Modeling of Cause and Effect Relationships in Nanoparticle
Formulation
|
3:25
3:45
p.m.
|
Inkyeom
Kim
SL
Histone
Deacetylase Inhibition Abolishes Development of
Hypertension Through Inhibition of Minealocorticoid
Receptor Transactivation in DOCA-Induced Hypertensive Rats
|
3:45
4:15
p.m.
|
Rakesh Kumar
IL
Revealing
an Essential Modifying Role of a Master Coregulator
in Promoting Breast-to-lung Metastasis
|
4:15
4:45
p.m.
|
Thomas
D.Y. Chung
IL
Partnering
with Governmental Programs/Agencies and Pharmaceutical/Biotechnology
Companies to Find New Medicines
|
|
3:25
3:45
p.m.
|
Y. El-Obedi
SL
Title Awaited
|
3:45
4:05
p.m.
|
Aishah
Adam
SL
Reducing
Pathogenicity in Type 2 Diabetes Mellitus (T2DM) by Targeting Oxidative
Stress
|
3:35
3:55
p.m.
|
Wael
M. Rabeh
SL
Correction
of the Misfolded Cystic Fibrosis Transmembrane
Conductance Regulator Channel is a Two-step Process
|
3:45
4:05
p.m.
|
Shadab
A. Siddiqi
SL
A
Novel Cell Biological Approach to Control Hyperlipidemia
|
4:15
4:35
p.m.
|
B. Rihova
SL
Therapy-dependent
Induct on of Systemic Anticancer Immune Response by Nanotherapeutics
|
4:45
5:15
p.m.
|
Bhushan
Patwardhan
IL
A
pharmacognosy perspective for innovations in
forging drug discovery partnerships
|
|
|
4:05
4:25
p.m.
|
Brett
A. Premack
SL
Leukotriene
A4 Hydrolase as a Novel Drug Target in Pulmonary Inflammation
|
3:55
4:25
p.m
|
Hideaki
Itoh
IL
70-kDa
Molecular Chaperone HSP70 is a Direct Target of Antibiotic Gentamicin
|
4:05
4:25
p.m.
|
Adrian
Angel Inchauspe
SL
Sudden,
Predictable and Preventable Death in Pharmacological Cardio Safety
|
4:35
4:55
p.m.
|
Rahila Najam
SL
Comparative
Metabolic Toxicity in Patients of Advanced Colorectal Carcinoma Treated with
Different Schedules of FOLFOX
|
|
|
4:25
4:45
p.m.
|
Dermot
Cox
SL
FcyRlla:
A Novel Drug Target in Infection and Inflammation
|
4:25
4:45
p.m.
|
Muhammad
Yusha'u
SL
Anti-Malarial
Activity of Cassia Sieberiana
Leaf Extracts
|
4:25
4:45
p.m.
|
Ashour
Eljamil
SL
Cholesterol
and Diet
|
|
|
Social
Mixer: 4:55 p.m. – 6:00 p.m.
The
buses will leave for hotels at 6:05 p.m.
[Back To Top]
|
|
DAY 2: Tuesday, February 19,
2013
|
|
JOINT PLENARY SESSION
|
|
Time
|
Chairman: H. Michel
Co-Chairman: Atta-ur-Rahman
|
Speaker
|
Title
|
|
9:00
9:45
a.m.
|
Location:
Auditorium
|
Ferid Murad
(Nobel Laureate)
PL
|
Discovery
of Nitric Oxide and Cyclic GMP Cell Signaling and Their Role in Drug
Development
|
|
9:45
10:30
a.m.
|
Location: Auditorium
|
Jean-Marie
Lehn (Nobel Laureate)
PL
|
From Supramolecular Chemistry Towards Adaptive Chemistry
Bioorganic and Drug Discovery Aspects
|
|
COFFEE BREAK: 10:30 – 11:00 a.m.
|
|
Locations
|
Lecture Hall 1
MPH 1
Top Floor:
Health Science Building
|
Lecture Hall 2
MPH 2
Top Floor:
Health Science Building
|
Lecture Hall 3
MPH 3
Top Floor:
Health Science Building
|
Lecture Hall 4
MPH 4
Top Floor:
Health Science Building
|
Lecture Hall 5
Room B 1001
Ground Floor:
Health Science Building
|
|
|
Chairman:
D.K. Lahiri
Co-Chairman:
H.C. Pant
|
Chairman:
F.Z. Basha
Co-Chairman:
S. Kenjeres
|
Chairman:
K. Jackowski
Co-Chairman:
C. Carfagna
|
Chairman:
T. Baum
Co-Chairman:
K. Yoshizaki
|
Chairman:
N.
Hattori
Co-Chairman:
Y. Sun
|
|
11:00
11:30
a.m.
|
Aurora
Martinez
IL
Screening
and Evaluation of Pharmacological Chaperones for Tyrosine Hydroxylase;
Correction of Neurotransmitter Deficiencies
|
11:00
11:30
a.m.
|
Thomas
Neumann
IL
High
Throughput Fragment Based Drug Discovery by SPR Imaging of Chemical
Microarrays
|
11:00
11:30
a.m.
|
Asier
Unciti-Broceta
IL
BOOM
Therapy Strategy – Spatially-Controlled Prodrug
Activation Mediated by Engineered Pd-Containing Devices
|
11:00
11:30
a.m.
|
James
W. Lillard, Jr.
IL
ANTI-CXCL
13 Antibody Therapy for Advanced Metastatic Prostate Cancer
|
11:00
11:30
a.m.
|
Michael
C. Pirrung
IL
Synthesis
and Biology of Natural Proteasome-inhibiting Anticancer Agents
|
|
11:30
12:00
noon
|
W.
Gibson Wood
IL
Statins
and Neuroprotection: Simvastatin-induced Upregulation of Bcl-2 In
vivo and In vitro
|
11:30
11:50
a.m.
|
Vaishali
Anil Kilor
SL
Design
and Development of Novel Microemulsion Based Topical
Formulation of Hesperidin
|
11:30
12:00
noon
|
Masahiko
Seki
IL
An
Efficient Catalytic System for C-H Activation: A Novel and Practical
Synthesis of Angiotensin II Receptor Blockers
|
11:30
11:50
a.m.
|
Tse
Wen Chang
SL
The
Combination of Anti-IgE Therapy and Specific
Immunotherapy for the Treatment of Allergic Diseases
|
11:30
11:50
a.m.
|
Krishna
P. Gupta
SL
Synergistic
Effects of Combination of Compounds in Controlling the Tumor Development:
Involvement of the Regulators of Tumorigenesis
|
|
12:00
12:30
p.m.
|
Masashi
Sakai
IL
Synaptic
Mechanism in the Primary Auditory Cortex (AI) Underlying Voice-Onset Time
(VOT) Dependent Categorical Perception: Relevance to Language Specific
Language Impairment (SLI)
|
11:50
12:10
p.m.
|
Adrian
Angel Inchauspe
SL
Risk
Management Project Applied to Torsadogenic Index
|
12:00
12:30
p.m.
|
Johan
Van der Eycken
IL
A
Modular Approach to Chiral Imidates: A New Class of
Nitrogen-Based Chiral Ligands as Tools for Medicinal Chemistry
|
11:50
12:20
p.m.
|
Piero
Procacci
IL
Characterization
and Optimization of Tartrate-based Tumor Necrosis Factor-alpha Converting
Enzyme Inhibitors
|
11:50
12:10
p.m.
|
Sayed K. Goda
SL
Production
of Novel Glucarpidases for More Efficient Cancer
Treatment and Detoxification of Drugs
|
|
12:30
12:50
p.m.
|
Youssef
Sari
SL
MS-153,
A Synthetic GLT1 Activator, Attenuates Ethanol Intake in Alcohol Preferring
Male Rats
|
12:10
12:30
p.m.
|
Subrata
Chakrabarti
SL
Accelerated
Wound Healing Using miRNA Antagomirs
in Normal and in Diabetic Conditions
|
12:30
12:50
p.m.
|
Muhammad
Naeem Khan
SL
Thiochromenopyridines-II: Antibacterial and antioxidant 9-benzylideneamino-5H-thiochromeno[2,3-b] pyridine-5-ones
|
12:20
12:40
p.m.
|
Afaf
Al Nadaf
SL
In
Silico
Search Culminate the Discovery of Low Micromolar β-Secretase Inhibitors
|
12:10
12:30
p.m.
|
Preeyanat Vongchan
SL
Thai
Medicinal Plant Extract "Hing-Hai" Inhibited
Adhesion of Colon Cancer Cell Line, SW 620
|
|
12:50
1:10
p.m.
|
Krzysztof
Jozwiak
SL
Novel
Positive Allosteric Modulators of the Human α7 Nicotinic Receptor
Modulate the Antidepressant Activity Elicited by Nicotine
|
12:30
12:50
p.m.
|
Rafi
Abd Al-Majeed Al-Razzuqi
SL
Is
Glucosamine-chondroitin Risky to Normoglycemic
Individuals with Family History of Diabetes Mellitus
|
12:50
1:10
p.m.
|
Sadiq
G. Uthman
SL
How
Birth Interval and Antenatal Care Affects Postpartum Haemorrhage
Prevention in Maiduguri, Nigeria: A Study of Misopristol
and Oxytocin
|
12:40
1:00
p.m.
|
Mohamed A. Morsy
SL
Protective Effects of Curcumin Against Indomethacin-induced Gastric Ulcer in
Rats: Role of iNOS, NF-κB, and caspase 3
|
12:30
1:00
p.m.
|
Alice
I. Yu
IL
Glycan-targeted
Cancer Immunotherapy
|
|
|
12:50
1:10
p.m.
|
R.
Perumal Samy
SL
Cationic
and Hydrophobic Peptides as Powerful Antibacterial and Wound Healing Agents
|
|
1:00
1:20
p.m.
|
Mohamed
Magdi
SL
Appraisal
of Histone Deacetylase Inhibitors as Possible Cure
for Breast Cancer
|
|
LUNCH BREAK: 1:10 – 2:00 p.m.
|
|
Locations
|
Lecture Hall 1
MPH 1
Top Floor:
Health Science Building
|
Lecture Hall 2
MPH 2
Top Floor:
Health Science Building
|
Lecture Hall 3
MPH 3
Top Floor:
Health Science Building
|
Lecture Hall 4
MPH 4
Top Floor:
Health Science Building
|
Lecture Hall 5
Room B 1001
Ground Floor:
Health Science Building
|
|
|
Chairman:
M.
Sakai
Co-Chairman:
Y. Sari
|
Chairman:
S.M. Lee
Co-Chairman:
M.S. Sharifi
|
Chairman:
A.U. Broceta
Co-Chairman:
J.V. Eycken
|
Chairman:
A. Khalid
Co-Chairman:
K. Jozwiak
|
Chairman:
M. Bebawy
Co-Chairman:
F. Huq
|
|
2:00
2:30
p.m.
|
Julianna Kardos
IL
Therapeutic
Potential of Neuro-glia Coupling in Epilepsy
|
2:00
2:30
p.m.
|
Brydon
Lawrence Bennett
IL
Advantages
and Challenges of Targeting Signal Transduction Pathways for Therapeutic
Intervention
|
2:00
2:20
p.m.
|
Karol
Jackowski
SL
Multinuclear
MR Spectroscopy in the Gas Phase
|
2:00
2:30
p.m.
|
Thomas
Baum
IL
Trabecular
Bone Structure Analysis of the Spine Using Clinical Multi-detector Computed
Tomography: Can it Predict Vertebral Bone Strength?
|
2:00
2:30
p.m.
|
Frank
Gansauge
IL
Effectivity of
Long Antigen Exposition Dendritic Cell Therapy (LANEX-DC)® in the Palliative
Treatment of Pancreatic Cancer
|
|
2:30
3:00
p.m.
|
Harish
C. Pant
IL
A
Novel Approach to Inhibit the Deregulation of the Kinases Involved in
Neurodegenerative Diseases
|
2:30
3:00
p.m.
|
Michael
G. Katze
IL
Systems
Biology and Viral Diseases: New Strategies for Identifying and Evaluating
Signatures, Targets, and Drugs
|
2:20
2:40
p.m.
|
Cosimo
Carfagna
SL
Mediterranean
Diet and Polymer Technology
|
2:30
3:00
p.m.
|
David
L. Brody
IL
Advanced
MRI Assessments of Brain White Matter Injury: Quantitative Radiological –
Pathological Correlations and Development of Imaging-based Pharmacodynamic Strategies
|
2:30
3:00
p.m.
|
Riyaz Basha
IL
Strategies
to Improve Therapeutic Responses in Treating Cancer
|
|
3:00
3:20
p.m.
|
Janos
Szolcsanyi
SL
Transient
Receptor Potentials of Trpv1 and Trpa1 as Targets for Analgesics on Nociceptors
|
3:00
3:30
p.m.
|
Tse
Wen Chang
IL
Updates
on Omalizumab and Anti-Cemx
– Antibodies Targeting the IgE Pathway
|
2:40
3:00
p.m.
|
Amina
A. Soayed
SL
Spectral,
Thermal and Biological Studies on Transition Metal Complexes of Moxifloxacin – Imidazole mixed Ligands
|
3:00
3:20
p.m.
|
Dipak
Maity
SL
Superparamagnetic
Iron Oxide Nanoparticles for Magnetic Resonance Imaging (MRI) Application
|
3:00
3:30
p.m.
|
Q.
Jane Wang
IL
PKD
Small Molecule Inhibitors: Discovery, Development and Therapeutic Potential
|
|
3:20
3:40
p.m.
|
Ornella Corazza
SL
New
Psychostimulant Agents Abuse
|
3:30
3:50
p.m.
|
Arjun
Surya
SL
Small
Molecule Modulators of the Kynurenin Pathway
|
3:00
3:20
p.m.
|
Abdollah
Javidan
SL
Asymmetric
Synthesis of New Spiro-oxindolopyrrolizidines
|
3:20
3:40
p.m.
|
Muhammad
Sohaib
SL
A
New Infection Imaging Agent Tc-99m Ceftriaxone: Labeling and Bio-distribution
in Animal Models
|
3:30
3:50
p.m.
|
Dorly de Freitas Buchi
SL
Pre-clinical
Results With a Highly Diluted Natural Complex, M1, as a Biologic Response
Modifier Against Melanoma
|
|
3:40
4:00
p.m.
|
Zeibun Ramtoola
SL
Octa-arginine modified PLGA nanoparticles enhances loperamide delivery to the brain
|
3:50
4:10
p.m.
|
Quadiri
Timour
SL
Protective
Effects of Ranolazine and Propranolol, alone or
Combined, on the Structural and Functional Alterations of Cardiomyocyte
Mitochondria in a Pig Model of Ischemia/Reperfusion
|
3:20
3:40
p.m.
|
Hadariah Bahron
SL
Schiff Base
Derived from m-phenylenediamine and o-vanillin and
its Dimeric Dinuclear and
Tetranuclear Co(II) and Zn(II) Complexes:
Physicochemical and Antimicrobial Studies
|
3:40
4:00
p.m.
|
Zainab
Al-Mohsen
SL
Attending
to Women's Sexual Health in Bahrain: Does Physician's Gender Make a
Difference?
|
3:50
4:10
p.m.
|
V. Badireenath Konkimalla
SL
Molecular
Modelling Approaches and Chemogenomic
Profiling of Naturally Occurring Compound as Potential EGFR-TK inhibitor
|
|
|
3:40
4:00
p.m.
|
Azita Azarkeivan
SL
Evaluation of
gastric side effects of new form of deferiprone (Entric coated) in patients with Thalassemia
|
|
|
Coffee
Break / Posters Session: 4:00 – 4:50 p.m.
Shopping
Visit: The buses will leave at 5:00 p.m.
[Back To Top]
|
|
DAY 3: Wednesday, February 20,
2013
|
|
JOINT PLENARY
SESSION
|
|
Time
|
Chairman: M.I. Choudhary
Co-Chairman: D.K. Lahiri
|
Speaker
|
Title
|
|
9:00
9:45
a.m.
|
Location: Auditorium
|
Richard
Lee Atkinson
PL
|
Role of Adenovirus 36 in Obesity,
Diabetes, and Breast Cancer: Potential Treatment and Prevention Options
|
|
9:45
10:30
a.m.
|
Location: Auditorium
|
Goverdhan Mehta
PL
|
Revisiting
Natural Products Chemistry: Synergy with Synthesis to Enhance Nature for
Human Health and Wellbeing
|
|
COFFEE BREAK: 10:30 – 11:00 a.m.
|
|
Locations
|
Lecture Hall 1
MPH 1
Top Floor:
Health Science Building
|
Lecture Hall 2
MPH 2
Top Floor:
Health Science Building
|
Lecture Hall 3
MPH 3
Top Floor:
Health Science Building
|
Lecture Hall 4
MPH 4
Top Floor:
Health Science Building
|
|
|
Chairman:
A. Martinez
Co-Chairman:
J.
Kardos
|
Chairman:
A. Khalid
Co-Chairman:
V.A. Kilor
|
Chairman:
B.L. Bennett
Co-Chairman:
M.G. Katze
|
Chairman:
J.-P. Renaud
Co-Chairman:
A. Kopylov
|
|
11:00
11:20
a.m.
|
Krzysztof
Jozwiak
SL
New
Derivatives of Fenoterol: A Versatile Tool to
Stimulate the β2 Adrenergic Receptor with Novel Therapeutic Perspectives
|
11:00
11:20
a.m.
|
Sergazy
Mynzhasarovich Adekenov
SL
Multidimensional Study of
Endemic Plant Species – Sources of New Medicinal Substances
|
11:00
11:30
a.m.
|
Jose
Freire
IL
Differential
Anti-Inflammatory Activity of Glucocorticoid and PDE 4 Inhibitors on
Neutrophils from COPD and Non-COPD Subjects
|
11:00
11:30
a.m.
|
Aung Naing
IL
A
Personalized, Pathway Specific Targeted Strategies for Solid Tumors
|
|
11:20
11:40
a.m.
|
Vidya Gopalakrishnan
SL
REST,
An Indicator of Poor Prognosis is a Novel Therapeutic Target for Medulloblastoma
|
11:20
11:40
a.m.
|
Vannina
Lorenzi
SL
Cellular Effects Induced
by Cistus Ladaniferus
Essential Oil and its Chromatographic Fractions on the Multi-drug Resistant Enterobacter Aerogenes EA289
Strain
|
11:30
12:00
noon
|
Kazuyuki
Yoshizaki
IL
Expansion
of Therapy with an Anti-IL-6R Antibody, Tocilizumab,
in Chronic Inflammatory Disease Based on the Pathogenic Analysis of IL-6
|
11:30
12:00
noon
|
Thierry
Langer
IL
Pharmacophores
and Their Efficient Use for Ligand Profiling
|
|
11:40
12:00
noon
|
Beata Sperlagh
SL
P2Y12
Receptor Antagonists: A New Approach for the Treatment of Inflammatory and
Neuropathic Pain
|
11:40
12:00
noon
|
Ana Ramirez de Molina
SL
Rosemary Extract as an
Adjuvant Agent to Overcome Chemoresistance of
Cancer Cells
|
12:00
12:20
p.m.
|
Prakash
Nagarkatti
SL
Aryl
Hydrocarbon Receptor (AhR) Ligands as Novel Drugs
in the Treatment of Autoimmune Diseases Target Signaling Pathways
|
12:00
12:30
p.m.
|
Erik
Van der Eycken
IL
Microwaves
in the Synthesis of Medium-sized Ring Drug Candidates
|
|
12:00
12:20
p.m.
|
Laila Kudsiova
SL
Delivery
of Anionic Versus Cationic Lipopolyplexes to the Brain by Convection Enhance
Delivery (CED) for the Treatment of Dementias
|
12:00
12:20
p.m.
|
Tamar Sanikidze
SL
Citrus Extract as an
Effective Remedy for the Correction of Metabolic Syndrome
|
12:20
12:40
p.m.
|
Mitzi
Nagarkatti
SL
Dietary
Indoles are Novel Immunosuppressive Agents Against
Inflammatory Diseases which Act by Modulating Epigenetic Regulation and miRNA Expression in T Cells
|
12:30
1:00
p.m.
|
Jin
U. Kang
IL
Real-time
3-D Fourier-domain Optical Coherence Tomography Video Image Guided
Microsurgeries
|
|
12:20
12:40
p.m.
|
W.
Gibson Wood
SL
Regulation
of the HMG-CoA Reductase Pathway in Alzheimer's
Disease: Specific Targeting of Isoprenoids but not
Cholesterol
|
12:20
12:50
p.m.
|
Thomas
Baum
IL
Magnetic
Resonance Imaging Based Cartilage T2 Relaxation Time Measurements as
Non-invasive Biomarker for Knee Osteoarthritis
|
12:40
1:00
p.m.
|
Mohammad
Sharif Sharifi
SL
Treatment
of Urticaria with Wet Cupping
|
1:00
1:20
p.m.
|
Nidhi
P. Sapkal
SL
Design,
Development, Scale Up and Validation of a Convenient and Cost Effective
Granulation Technology for the Formulation of Tablets Using Conventional
Excipients
|
|
12:40
1:00
p.m.
|
James
W. Lillard, Jr.
SL
XPCLAD
Nanoreformulation of Cisplatin
for Prostate Cancer
|
12:50
1:20
p.m.
|
Marc
Arnold
IL
Discovery
and Development of Universal Fc Binders for Antibody Purification
|
1:00
1:20
p.m.
|
Sung
Mun Lee
SL
Novel
Oral Drug Delivery System for Inflammatory Diseases
|
1:20
1:40
p.m.
|
Sergey
A. Tarasov
SL
Novel
Opportunity for Pharmacological Regulation of Endogeneous
Targets by Antibodies in Release Active Form
|
|
1:00
1:20
p.m.
|
Taj
Ur Rehman
SL
A
Sunlight-induced Method for Rapid Biosynthesis of Silver Nanoparticles Using
an Andrachnea Chordifolia
Ethanol Extract
|
1:20
1:40
p.m.
|
Azita
Azarkeivan
SL
Evaluation
of Gastric Side Effects of New Form of Deferiprone,
(L1; Enteric Coated)
|
1:20
1:40
p.m.
|
Azza
Altawashi
SL
CC2D1A
Links cAMP Signaling to Non-syndromic
Mental Retardation
|
1:40
2:00
p.m.
|
Carmay
Lim
SL
Novel
Zn Finger Drug Targets
|
|
LUNCH BREAK: 2:00 – 3:00 p.m.
POSTER SESSION: 3:00 – 4:25 p.m.
|
|
Poster
Session: 3:00 – 4:25 p.m.
Departure
for Gala Dinner at 4:30 p.m.
The
buses will leave for hotels at 9:30 p.m.
[Back To Top]
|
|
DAY 4: Thursday, February 21,
2013
|
|
JOINT
PLENARY SESSION
|
|
Time
|
Chairman: Taleb-Al-Tel
Co-Chairman:
R. Kumar
|
Speaker
|
Title
|
|
9:00
9:45
a.m.
|
Location: Auditorium
|
Muhammad
Iqbal Choudhary
PL
|
Discovery
of Anti-Infective and Multi-drug Resistance Reversal Agents
|
|
9:45
10:30
a.m.
|
Location: Auditorium
|
Debomoy K. Lahiri
PL
|
MicroRNA to Study Physiological
Regulation of Gene Products Implicated in CNS Disorders: Discovery of Novel
APP and BACE-specific MicroRNAs Important for Alzheimer's Disease
|
|
Locations
|
Lecture Hall 1
MPH 1
Top Floor:
Health Science Building
|
Lecture Hall 2
MPH 2
Top Floor:
Health Science Building
|
Lecture Hall 3
MPH 3
Top Floor:
Health Science Building
|
Lecture Hall 4
MPH 4
Top Floor:
Health Science Building
|
|
|
Chairman:
V. Smirnov
Co-Chairman:
J. Yu
|
Chairman:
A.F. Vanin
Co-Chairman: L.
Torun
|
Chairman:
T. Langer
Co-Chairman:
J.U. Kang
|
Chairman:
V. Lorenzi
Co-Chairman:
C. Lim
|
|
10:35
10:55
a.m.
|
Evgenij Germanovich
Skurikhin
SL
Antifibrotic Effects of Reserpine on
Lung Fibrosis, Haematopoietic Stem Cells in the
Pathogenesis of Pneumofibrosis
|
10:35
11:05
a.m.
|
Drazen
Raucher
IL
Thermally
Targeted Delivery of a c-Myc Inhibitory Peptide to
Breast and Brain Tumors In vivo Using Elastin-like Polypeptide
|
10:35
11:05
a.m.
|
Don
S. Richards
IL
Simultaneous
Quantitative and Qualitative DMPK Measurements Using a Quadrupole-time-of-Flight
Mass Spectrometer
|
10:35
11:05
a.m.
|
Felix-Martin
Werner
IL
Therapeutic
Options in the Treatment of Generalized Epilepsy According to a Neuronal
Network
|
|
10:55
11:15
a.m.
|
Safa Fitouri
SL
Design,
Synthesis and Biological Evaluation of some Triazole
Schiff's Base Derivatives as Potentials Anti – Tubercular Agents
|
11:05
11:35
a.m.
|
Luc
Van Hijfte
IL
Biophysical
Technologies Applied to Fragment Based Drug Discovery: Discovery of a New
Series of PIM1/3 Selective Kinase Inhibitors
|
11:05
11:25
a.m.
|
Alexey
Kopylov
SL
Apta-miniLego
for Thrombin Inhibitors: New Insights into Nano-module Construction
|
11:05
11:35
a.m.
|
Alan
Prem Kumar
IL
The
Key "Missing" Regulator and Therapeutic Target for NFkB-induced
Metastasis in Human Breast Cancer
|
|
11:15
11:35
a.m.
|
Evgenij Germanovich
Skurikhin
SL
Antifibrotic Properties of Pegylated Hyaluronidase in Pneumofibrosis. Spiperone Increases the Effects of Pegylated
Hyaluronidase
|
|
|
COFFEE BREAK: 11:30 – 12:00 noon
|
|
Locations
|
Lecture Hall 1
MPH 1
Top Floor:
Health Science Building
|
Lecture Hall 2
MPH 2
Top Floor:
Health Science Building
|
Lecture Hall 3
MPH 3
Top Floor:
Health Science Building
|
Lecture Hall 4
MPH 4
Top Floor:
Health Science Building
|
|
|
Chairman: W.G. Wood
Co-Chairman: B. Sperlagh
|
Chairman: Q. Timour
Co-Chairman:
S.A. Siddiqi
|
Chairman:
D. Raucher
Co-Chairman: L.V.
Hijfte
|
Chairman:
M. Seki
Co-Chairman:
S.M. Adekenov
|
|
12:00
12:30
p.m.
|
Debomoy
K. Lahiri
IL
Neuroprotective
and Neuropreservative Effects of Nutraceuticals in Neuronal Cultures: Potential Preventive
and Therapeutic Strategies in Alzheimer's Disease (AD)
|
12:00
12:30
p.m.
|
Yulia
Komarova
IL
End
Binding Protein 3: A Novel Target for Treating Acute Lung Injury
|
12:00
12:30
p.m.
|
Jean-Paul
Renaud
IL
Noncovalent
Mass Spectrometry Combined with X-ray Crystallography and Other Biophysical
Techniques for Drug Discovery
|
12:00
12:30
p.m.
|
Gerhard
Muller
IL
Novel
Kinase Inhibitors with Pre-engineered Slow Off-rates
|
|
12:30
12:50
p.m.
|
Nadia
Mohamed Said Arafa
SL
Prophylactic
Effect of Hypericum Perforatum
Extract in Scopolamine Rat Model of Cognitive Dysfunction
|
12:30
12:50
p.m.
|
Dipak
P. Ramji
SL
Signalling
Pathways Underlying Interferon-ν Actions in Atherosclerosis
|
12:30
1:00
p.m.
|
Anatoly
F. Vanin
IL
Dinitrosyl
Iron Complexes With Thiol-Containing Ligands as a
Base for New-generation Drugs
|
12:30
1:00
p.m.
|
Taleb
H. Al-Tel
IL
Single
Building Block Architecture: Toward the Design and Discovery of Novel and
Tissue Selective Anticancer Drug Leads
|
|
12:50
1:10
p.m.
|
Youssef
Sari
SL
Ceftriaxone
Attenuates Alcohol Intake Through Regulatory Effects of Both GLT1 and ENT1 in
Central Reward Brain Regions in Alcohol-preferring Rats
|
12:50
1:10
p.m.
|
InKyeom
Kim
SL
Recruitment
of Specificity Protein 1 by CpG Hypomethylation
Upregulates Na+-K+-2CI-
Contransporter 1 in Hypertensive Rats.
|
1:00
1:20
p.m.
|
Lokman
Torun
SL
New
Aryl Substituted Oxatropenes: Synthesis and
Biological Profiles
|
1:00
1:20
p.m.
|
Zehra
Naz
SL
Is
Fructose an Ideal Sweetening Agent?
|
|
1:10
1:30
p.m.
|
Felix-Martin
Werner
SL
Novel
Therapeutic Options in Major Depression According to a Neuronal Network
|
1:10
1:30
p.m.
|
Vera
A. Spiridonova
SL
DNA
Aptamers as Therapeutic Agents
|
1:20
1:40
p.m.
|
Asaad
Khalid Ahmed
SL
Discovery
of TB Drugs from African Medicinal Plants The Road to EI Dorado
|
1:20
1:40
p.m.
|
Gerhard
Muller
SL
Privileged
Structures in Medicinal Chemistry Unlocking the PDE, GPCR, and Epigenetic
Target Space
|
|
1:30
1:50
p.m.
|
Harish
C. Pant
SL
Role
of Topographic Phosphorylation in the Nervous System
|
1:30
1:50
p.m.
|
Tamar
Sanikidze
SL
Antiatherogenic
Effectiveness of Georgian Red Grape
|
|
1:40
2:00
p.m.
|
Helmut
Durchschlag
SL
Development
of Anti-Radiation Drugs
|
|
LUNCH BREAK: 2:00 – 3:00 p.m.
POSTER PRESENTATIONS: 3:00 – 4:00 p.m.
CASH PRIZE ANNOUNCEMENT FOR THREE BEST POSTERS:
4:00 p.m.
POSTER PRESENTER'S PRESENCE IS ESSENTIAL TO
RECEIVE THE CASH AWARD AND CERTIFICATE OF MERIT
|
|
Departure
for City Tour at 4:15 p.m.
IMPORTANT: The buses will leave daily from all Hotels at 8:15 a.m.
for the conference venue.
PL: Plenary Lecture
JL: Julphar
Lecture
IL: Invited Lecture
SL: Session Lecture
[Back To Top]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
